These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 17659713)
21. Visceral adiposity is closely correlated with neck circumference and represents a significant indicator of insulin resistance in WHO grade III obesity. Yang L; Samarasinghe YP; Kane P; Amiel SA; Aylwin SJ Clin Endocrinol (Oxf); 2010 Aug; 73(2):197-200. PubMed ID: 20050862 [TBL] [Abstract][Full Text] [Related]
22. Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease. Kojima H; Sakurai S; Uemura M; Takekawa T; Morimoto H; Tamagawa Y; Fukui H Alcohol Clin Exp Res; 2005 Dec; 29(12 Suppl):259S-63S. PubMed ID: 16385233 [TBL] [Abstract][Full Text] [Related]
23. [NASH in children]. Ida S; Yoshimura N Nihon Rinsho; 2006 Jun; 64(6):1168-72. PubMed ID: 16768127 [TBL] [Abstract][Full Text] [Related]
24. Obesity and liver disease. Scheen AJ; Luyckx FH Best Pract Res Clin Endocrinol Metab; 2002 Dec; 16(4):703-16. PubMed ID: 12468416 [TBL] [Abstract][Full Text] [Related]
25. Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse. Sterling RK; Smith PG; Brunt EM J Clin Gastroenterol; 2013 Feb; 47(2):182-7. PubMed ID: 23059409 [TBL] [Abstract][Full Text] [Related]
26. The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment. Ballestri S; Nascimbeni F; Romagnoli D; Lonardo A Hepatol Res; 2016 Oct; 46(11):1074-1087. PubMed ID: 26785389 [TBL] [Abstract][Full Text] [Related]
27. Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease. Ferreira DM; Castro RE; Machado MV; Evangelista T; Silvestre A; Costa A; Coutinho J; Carepa F; Cortez-Pinto H; Rodrigues CM Diabetologia; 2011 Jul; 54(7):1788-98. PubMed ID: 21455726 [TBL] [Abstract][Full Text] [Related]
28. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease. Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833 [TBL] [Abstract][Full Text] [Related]
29. The Association of Upper Body Obesity with Insulin Resistance in the Newfoundland Population. Youssef S; Nelder M; Sun G Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34072554 [TBL] [Abstract][Full Text] [Related]
30. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. van der Poorten D; Milner KL; Hui J; Hodge A; Trenell MI; Kench JG; London R; Peduto T; Chisholm DJ; George J Hepatology; 2008 Aug; 48(2):449-57. PubMed ID: 18627003 [TBL] [Abstract][Full Text] [Related]
31. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls. Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295 [TBL] [Abstract][Full Text] [Related]
32. Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men. Park SH; Kim BI; Kim SH; Kim HJ; Park DI; Cho YK; Sung IK; Sohn CI; Kim H; Keum DK; Kim HD; Park JH; Kang JH; Jeon WK J Am Coll Nutr; 2007 Aug; 26(4):321-6. PubMed ID: 17906183 [TBL] [Abstract][Full Text] [Related]
33. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology. Jung KY; Cho SY; Kim HJ; Kim SB; Song IH J Clin Gastroenterol; 2014; 48(10):883-8. PubMed ID: 24440936 [TBL] [Abstract][Full Text] [Related]
34. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease. Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480 [TBL] [Abstract][Full Text] [Related]
35. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity. Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682 [TBL] [Abstract][Full Text] [Related]